Our exclusive offer to CROs

At Lambda-Plus, we pride ourselves on offering our partner CROs the most flexible collaboration model to complement their respective range of services.

 

Read more

At Lambda-Plus, we pride ourselves on offering our partner CROs the most flexible collaboration model to complement their respective range of services.

While some CROs are licensing one or several EDC software applications for supporting their other core services, others are relying on providers like Lambda-Plus to design study-specific electronic data capture and electronic data management applications.

In an ever changing and always more demanding research landscape, the complexity of clinical trials has been increasing at a blistering pace. Licensed software does not always offer flexibility sufficient to matching of the requirements on trials perfectly.

Lambda-Plus is offering CROs multiple web-based, combined or stand-alone eCRF, IWRS (on-line randomization), Drug Supply Management (DSM) and ePRO/eCOA/eDiary applications that have been customized to meet needs specific to CROs and studies.

Lambda-Plus’ primary objective is to complement CRO partners’ respective services with a win-win approach. Therefore, Lambda-Plus applications may be connected to external data sources and systems (e.g. connecting a Lambda-Plus eDiary application to an external EDC system), which will then provide full flexibility to CRO partners.

P3: Priviledged Partner Program

P3, the Lambda-Plus Privileged Partner Program, is an exclusive opportunity which Lambda-Plus is offering to its CRO partners.

 

Read more

P3, the Lambda-Plus Privileged Partner Program, is an exclusive opportunity which Lambda-Plus is offering to its CRO partners. The program is based on a very personalized support, which allows first-line dedicated support of the partners with regard to sponsors, on the one hand and on the other hand, streamlined interactions while studies are being set up, conducted and completed.

However Lambda-Plus is committed to granting privilege to a restricted number of CROs adhering to P3 and then offering them a significant competitive advantage. Interested? Feel free to contact us.

Our added values for CROs

  • Three decades of experience with Phase I to Phase III (complex) clinical trials, managed access programs and post-marketing projects.
  • Combined expertise in eClinical solutions with a background in CRO...

Read more

  • Three decades of experience with Phase I to Phase III (complex) clinical trials, managed access programs and post-marketing projects.
  • Combined expertise in eClinical solutions with a background in CRO
  • Flexibility guaranteed thanks to:
    • the customization of a wide range of EDC solutions eCRF, IWRS (on-line randomization), Drug Supply Management (DSM) and ePRO/eCOA/eDiary that will be developed by Lambda-Plus using its proprietary and validated software
    • the capability to allow interactions with other systems and data sources
  • Cost-effectiveness thanks to license-free solutions (no impact on budgets of the number of sites, patients and volume of collected data)
  • Very strong focus on quality and adherence to applicable guidelines and regulations

How we are different

We are much more than just an EDC solution provider. Indeed we:

  • offer our partnering CROs our long-lasting eClinical experience in customizing the right environment to... 

Read more

We are much more than just an EDC solution provider. Indeed we:

  • offer our partnering CROs our long-lasting eClinical experience in customizing the right environment to collect and manage study data
  • know CRO concerns and always suggest the most appropriate solution using our own systems and customize it to match CRO-specific requirements
  • support our CRO partners from their initial contact with sponsors and then from study setup through study completion
  • streamline interactions between all clinical trials stakeholders, whether they are from sites, from the CRO and from the Sponsor
  • develop EDC solutions that can combine multiple data sources or simply work as stand-alone applications (e.g. eCRF, IWRS or ePRO only)
  • have a very strong focus on user-friendliness and keeping end-users training to just a few minutes

 

Testimonials

Lambda-Plus signs a global collaboration agreement with a Belgian biotech company

 

Lambda-Plus will exhibit at the Annual Conference of the Association for Clinical Data Management (ACDM) that will be held in Brussels on 14th March 2017.
Read more on ACDM conference website

Lambda-Plus will exhibit at the 6th Day of Clinical Research that will be held in Paris on 26th Jan. 2017.